珈诚生物 (832022.OC)

+ 收藏

现金流量表(珈诚生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 67,015,313.64167,335,256.1467,420,959.85158,828,193.9566,636,656.61
 收到其他与经营活动有关的现金(元) 6,398,571.9211,575,598.9312,816,356.467,143,359.836,615,074.47
 经营活动现金流入小计(元) 73,413,885.56178,910,855.0780,237,316.31165,971,553.7873,251,731.08
 购买商品、接受劳务支付的现金(元) 49,772,148.94104,203,864.5242,763,462.37134,321,207.5980,355,501.75
 支付给职工以及为职工支付的现金(元) 6,198,980.9411,753,311.706,497,345.627,037,937.023,664,887.94
 支付的各项税费(元) 6,621,253.5514,077,666.979,614,915.7510,154,480.925,570,908.02
 支付其他与经营活动有关的现金(元) 5,247,498.2410,058,206.318,273,914.1614,676,028.439,053,351.58
 经营活动现金流出小计(元) 67,839,881.67140,093,049.5067,149,637.90166,189,653.9698,644,649.29
 经营活动产生的现金流量净额(元) 5,574,003.8938,817,805.5713,087,678.41-218,100.18-25,392,918.21
二、投资活动产生的现金流量
 收回投资收到的现金(元) 9,916,100.00--2,000,000.00-
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) ---11,000.00-
 投资活动现金流入小计(元) 9,916,100.00--2,011,000.00-
 购建固定资产、无形资产和其他长期资产支付的现金(元) 310,000.006,516,396.585,458,799.7136,156,031.18638,513.27
 取得子公司及其他营业单位支付的现金净额(元) -----22,449.21
 投资活动现金流出小计(元) 310,000.006,516,396.585,458,799.7136,156,031.18616,064.06
 投资活动产生的现金流量净额(元) 9,606,100.00-6,516,396.58-5,458,799.71-34,145,031.18-616,064.06
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---20,000,000.00-
  其中:子公司吸收少数股东投资收到的现金(元) ---20,000,000.00-
 取得借款收到的现金(元) 18,000,000.0037,736,410.2027,736,410.20-24,600,000.00
 筹资活动现金流入小计(元) 18,000,000.0037,736,410.2027,736,410.2020,000,000.0024,600,000.00
 偿还债务支付的现金(元) 26,000,000.0033,416,410.2024,435,622.002,290,000.0010,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 5,453,058.3713,392,662.5312,790,776.1013,539,681.2112,636,463.90
 支付其他与筹资活动有关的现金(元) 1,500,460.342,914,350.742,596,340.682,416,299.474,813,698.92
 筹资活动现金流出小计(元) 32,953,518.7149,723,423.4739,822,738.7818,245,980.6827,450,162.82
 筹资活动产生的现金流量净额(元) -14,953,518.71-11,987,013.27-12,086,328.581,754,019.32-2,850,162.82
五、现金及现金等价物净增加额(元) 226,585.1820,314,395.72-4,457,449.88-32,609,112.04-28,859,145.09
 加:期初现金及现金等价物余额(元) 35,622,640.5815,308,244.8615,308,244.8647,917,356.9047,917,356.90
 期末现金及现金等价物余额(元) 35,849,225.7635,622,640.5810,850,794.9815,308,244.8619,058,211.81
补充资料:
 净利润(元) 3,648,831.0317,991,214.7110,426,929.7312,039,271.015,010,180.58
 资产减值准备(元) -284,999.22142,499.61284,999.22-
 固定资产和投资性房地产折旧(元) 2,033,220.812,822,212.63645,669.111,111,420.10551,493.00
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 2,033,220.812,822,212.63645,669.111,111,420.10551,493.00
 无形资产摊销(元) 35,000.0070,000.0035,000.0070,000.0040,833.33
 长期待摊费用摊销(元) 1,251,571.381,657,223.32406,795.84--
 处置固定资产、无形资产和其他长期资产的损失(元) -8,990.02---2,645.45-
 财务费用(元) 790,513.101,659,597.88866,871.831,758,323.83710,014.64
 投资损失(元) 38,680.33118,075.9963,232.31921,093.582,421,475.29
 递延所得税(元) -51,936.25249,266.90-70,651.43553,500.45450,247.54
  其中:递延所得税资产减少(元) -51,936.25249,266.90-70,651.43553,500.45450,247.54
 存货的减少(元) 4,299,290.40-3,164,551.9127,472,426.98-31,839,023.53-9,382,469.87
 经营性应收项目的减少(元) -601,733.6610,635,042.08-780,466.45-4,457,584.47-17,706,573.57
 经营性应付项目的增加(元) -7,084,710.914,294,824.78-27,756,418.6516,311,329.68-10,455,350.03
 其他(元) -263,160.00263,160.00-263,160.00-
 现金的期末余额(元) 35,849,225.7635,622,640.5810,850,794.9815,308,244.8619,058,211.81
 减:现金的期初余额(元) 35,622,640.5815,308,244.8615,308,244.8647,917,356.9047,917,356.90
 现金及现金等价物的净增加额(元) 226,585.1820,314,395.72-4,457,449.88-32,609,112.04-28,859,145.09
公告日期 2024-08-282024-04-252023-08-302023-04-252022-08-26
审计意见(境内) 带强调事项段的无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院